Full Text (PDF)
Case Report

Surface Mould Brachytherapy in Recurrent Basal Cell Carcinoma of Ala of Nose: A Case Report

Taher Manaquibwala null, Taher Manaquibwala1 null, Saurabh Karnawat2 null, Ashar Iqbal Lodi3 null, Amresh Kumar4 null, Virendra Bhandari5 null

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Cancer Education and Research 10(1):p 39-42, January - June 2022. | DOI: https://doi.org/10.21088/ijcer.2321.9815.10122.5

How Cite This Article:

Taher Manaquibwala, Saurabh Karnawat, Ashar Iqbal Lodi, et. al./Surface Mould Brachytherapy in Recurrent Basal Cell Carcinoma of Ala of Nose: A Case Report/Indian J Canc Educ Res 2022;10(1):39-42.


Timeline

Received : October 12, 2021         Accepted : November 19, 2021          Published : June 05, 2022

Abstract

Basal cell carcinoma accounts for at least 32% of all cancers globally. Of skin cancers other than melanoma, about 80% are basal cell carcinomas. Basal cell carcinoma commonly presents as ulcerative lesions on the exposed parts of the face. Modalities for the treatment of basal cell carcinoma include surgical excision, cryotherapy, and radiotherapy. This article presents case report of a middle aged female with recurrent basal cell carcinoma of the ala of nose treated with surface mould brachytherapy


References

  • 1.   Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015 Jun 1;88(2):167-79.
  • 2.   Goldberg LH, Rubin HA. Management of basal cell carcinoma. Which option is best? Postgrad Med. 1989 Jan; 85(1):57-8, 61-3.
  • 3.   Hacker SM, Browder JF, Ramos-Caro FA. Basal cell carcinoma. Choosing the best method of treatment for a particular lesion. Postgrad Med. 1993 Jun;93(8):101-4, 106-8, 111.
  • 4.   Clark CM, Furniss M, Mackay-Wiggan JM. Basal cell carcinoma: an evidence-based treatment update. Am J Clin Dermatol. 2014 Jul;15(3):197- 216.
  • 5.   Prickett KA, Ramsey ML. Mohs Micrographic Surgery. [Updated 2021 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
  • 6.   Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989 Apr;15(4):424-31.
  • 7.   Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules. Dermatol Surg. 1996 Oct;22(10):854-8.
  • 8.   Nordin P, Larkö O, Stenquist B. Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs' surgery. Br J Dermatol. 1997 Feb;136(2):1803.
  • 9.   Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg. 2003 Jun;29(6):566-71.
  • 10.   Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003412. doi: 10.1002/14651858. CD003412.pub2. Update in: Cochrane Database Syst Rev. 2020 Nov 17;11:CD003412.
  • 11.   Skowronek J. Brachytherapy in the treatment of skin cancer: an overview. Postepy Dermatol Alergol. 2015 Oct;32(5):362-7.
  • 12.   Casey S, Awotwi-Pratt J, Bahl G. Surface Mould Brachytherapy for Skin Cancers: The British Columbia Cancer Experience. Cureus. 2019 Dec 18;11(12):e6412.
  • 13.   Delishaj D, Rembielak A, Manfredi B, Ursino S, Pasqualetti F, Laliscia C, Orlandi F, Morganti R, Fabrini MG, Paiar F. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature. J Contemp Brachytherapy.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Taher Manaquibwala, Saurabh Karnawat, Ashar Iqbal Lodi, et. al./Surface Mould Brachytherapy in Recurrent Basal Cell Carcinoma of Ala of Nose: A Case Report/Indian J Canc Educ Res 2022;10(1):39-42.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
October 12, 2021 November 19, 2021 June 05, 2022

DOI: https://doi.org/10.21088/ijcer.2321.9815.10122.5

Keywords

Basal cell carcinomaRecurrentBrachytherapySurface mould

Article Level Metrics

Last Updated

Friday 31 July 2026, 15:28:14 (IST)


1318

Accesses

10
266
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received October 12, 2021
Accepted November 19, 2021
Published June 05, 2022

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share